- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Harris & Harris Group, Inc. (Nasdaq:TINY), an early-stage, active investor in transformative companies, is pleased to work with Burroughs Wellcome Fund and Research Triangle Foundation to support new thinking in the healthcare space. The Global Vision Forum was initiated by a group of Eisenhower Fellows interested in bringing global leaders to the United States in an effort to drive new ideas into critical issues. The two-day event included meetings with leading healthcare officials and innovators. The inaugural event was held on October 3rd and 4th in Research Triangle Park, NC.
The discussions focused on the major challenges of the United States' healthcare system and potential learning from outside the United States. Dr. Kongkiat Kespechara from Thailand was invited to join the discussions. Dr. Kespechara is a global thought leader in integrating medical diagnostic data with novel approaches in agriculture to produce major improvements in patient outcomes. "As innovators in early-stage technology, we believe it is important to be on the leading edge of this discussion," stated Douglas W. Jamison, the CEO of Harris & Harris Group. "Burroughs Wellcome Fund and Research Triangle Foundation are leading organizations in the healthcare field, and we are pleased to work with them in initiating this important dialogue," added Rob Burns, Senior Vice President at Harris & Harris Group.
About Harris & Harris Group, Inc.
Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com and on Facebook at www.facebook.com/harrisharrisvc.
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references to the websites www.HHVC.com and www.Facebook.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.
For more information, please click here
DOUGLAS W. JAMISON
TEL. NO. (212) 582-0900
Copyright © Harris & Harris Group, Inc.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
RMIT researchers make leap in measuring quantum states July 21st, 2016
Graphene photodetectors: Thinking outside the 2-D box July 21st, 2016
Nanometrics Announces Upcoming Investor Events July 20th, 2016